JP2023522331A5 - - Google Patents
Info
- Publication number
- JP2023522331A5 JP2023522331A5 JP2022562728A JP2022562728A JP2023522331A5 JP 2023522331 A5 JP2023522331 A5 JP 2023522331A5 JP 2022562728 A JP2022562728 A JP 2022562728A JP 2022562728 A JP2022562728 A JP 2022562728A JP 2023522331 A5 JP2023522331 A5 JP 2023522331A5
- Authority
- JP
- Japan
- Prior art keywords
- solid form
- compound
- xrpd
- theta
- angles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025122305A JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063011776P | 2020-04-17 | 2020-04-17 | |
| US63/011,776 | 2020-04-17 | ||
| PCT/US2021/027620 WO2021211930A1 (en) | 2020-04-17 | 2021-04-16 | Forms and compositions of inhibitors of plasma kallikrein |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122305A Division JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023522331A JP2023522331A (ja) | 2023-05-30 |
| JP2023522331A5 true JP2023522331A5 (https=) | 2024-04-26 |
Family
ID=75870731
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562728A Pending JP2023522331A (ja) | 2020-04-17 | 2021-04-16 | 血漿カリクレインの阻害剤の形態及び組成物 |
| JP2025122305A Pending JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025122305A Pending JP2025142238A (ja) | 2020-04-17 | 2025-07-22 | 血漿カリクレインの阻害剤の形態及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230167132A1 (https=) |
| EP (2) | EP4623913A3 (https=) |
| JP (2) | JP2023522331A (https=) |
| DK (1) | DK4136091T3 (https=) |
| ES (1) | ES3035604T3 (https=) |
| FI (1) | FI4136091T3 (https=) |
| PL (1) | PL4136091T3 (https=) |
| PT (1) | PT4136091T (https=) |
| WO (1) | WO2021211930A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019028362A1 (en) * | 2017-08-04 | 2019-02-07 | Dyax Corp. | INHIBITORS OF PLASMATIC KALLIKREIN AND USES THEREOF |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| EP1596869B1 (en) * | 2003-01-21 | 2014-06-04 | New Form Pharmaceuticals Inc. | Novel cocrystallization |
| WO2011115069A1 (ja) * | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 結晶の網羅的探索 |
| CN110015955A (zh) * | 2010-07-23 | 2019-07-16 | 格吕伦塔尔有限公司 | 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体 |
| WO2012097333A2 (en) * | 2011-01-14 | 2012-07-19 | Redwood Bioscience, Inc. | Aldehyde-tagged immunoglobulin polypeptides and method of use thereof |
| EP3765459A1 (en) | 2018-03-13 | 2021-01-20 | Shire Human Genetic Therapies, Inc. | Substituted imidazopyridines as inhibitors of plasma kallikrein and uses thereof |
-
2021
- 2021-04-16 EP EP25178752.9A patent/EP4623913A3/en active Pending
- 2021-04-16 EP EP21724430.0A patent/EP4136091B1/en active Active
- 2021-04-16 ES ES21724430T patent/ES3035604T3/es active Active
- 2021-04-16 US US17/919,212 patent/US20230167132A1/en active Pending
- 2021-04-16 DK DK21724430.0T patent/DK4136091T3/da active
- 2021-04-16 WO PCT/US2021/027620 patent/WO2021211930A1/en not_active Ceased
- 2021-04-16 PL PL21724430.0T patent/PL4136091T3/pl unknown
- 2021-04-16 FI FIEP21724430.0T patent/FI4136091T3/fi active
- 2021-04-16 PT PT217244300T patent/PT4136091T/pt unknown
- 2021-04-16 JP JP2022562728A patent/JP2023522331A/ja active Pending
-
2025
- 2025-07-22 JP JP2025122305A patent/JP2025142238A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11724986B2 (en) | Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use | |
| JP7789850B2 (ja) | Ｌｎｐ０２３の結晶形態 | |
| CN105209437B (zh) | 心肌肌球蛋白激动剂的盐和制备盐的方法 | |
| JP2017505796A5 (https=) | ||
| JP2014530805A (ja) | アジルサルタンの結晶形並びにその製造及び使用 | |
| CN107427503A (zh) | 2‑(5‑(3‑氟苯基)‑3‑羟基吡啶甲酰胺)乙酸的固体形式、其组合物及用途 | |
| CN110678455B (zh) | 3-苯基-4-丙基-1-(吡啶-2-基)-1h-吡唑-5-醇盐酸盐的新颖结晶型固体化合物 | |
| WO2016131431A1 (en) | Solid forms of empagliflozin | |
| JP2019504033A (ja) | 選択的なｓ１ｐ１受容体アゴニストの新規な結晶形及びその製造方法 | |
| JP7314319B2 (ja) | Ｃｄｋ９阻害剤の結晶多形体及びその製造方法と用途 | |
| KR20250048080A (ko) | 나프틸아민계 미토파지 유도제의 고체 형태, 이의 제조 방법, 약학 조성물 및 용도 | |
| KR20200030106A (ko) | 빌란테롤 트리페나테이트의 신규의 결정형 및 이들의 제조방법 | |
| JP2023522331A5 (https=) | ||
| CN102232070A (zh) | (r)-5-((e)-2-(吡咯烷-3-基乙烯基)嘧啶的合成和新的盐形式 | |
| JP2016512518A (ja) | ベムラフェニブ塩酸塩の固体形態 | |
| CN101627026A (zh) | 晶体盐酸度洛西汀 | |
| US7820716B2 (en) | Crystalline polymorphs of desvenlafaxine succinate and their preparations | |
| TWI765086B (zh) | Parp-1抑制劑的晶型及其製備方法 | |
| TWI666207B (zh) | 一種苯并哌啶類衍生物的鹽、其晶型及鹽、其晶型的製備方法 | |
| JP2021530526A5 (https=) | ||
| CN114075169B (zh) | 奥希替尼药用共晶体及其制备方法 | |
| CN111108098B (zh) | 一种炔基吡啶类脯氨酰羟化酶抑制剂的晶型及其制备方法 | |
| JP2018030884A (ja) | テノホビルの固体形態 | |
| JP7617043B2 (ja) | ｔｅｒｔ－ブチル（Ｓ）－２－（（２Ｓ，３Ｒ）－１－アミノ－３－ヒドロキシ－１－オキソブタン－２－イル）－１－オキソ－２，５－ジアザスピロ［３．４］オクタン－５－カルボキシレートの固体形態およびそれらを調製する方法 | |
| JP2022524741A5 (https=) |